Share
Arbor Research Collaborative for Health, a Michigan-based 501(c)3 nonprofit corporation, is proud to announce the award of the General Services Administration (GSA) Multiple Award Schedule contract to its subsidiary, Arbor Research LLC under SINs 541611 and 541715.
Arbor Research LLC qualifies as a small business under the associated NAICS codes and will seek additional SINs as the organization evolves and expands its mission impact. The federal government has placed continued importance on expanding its contracting with small businesses to reach or exceed its small business goals; Arbor Research LLC looks forward to supporting these efforts.
“We are thrilled to achieve this designation and expand our ability to serve government clients,” said Christopher Spera, PhD, President and CEO of Arbor Research Collaborative for Health. “This award underscores our dedication to advancing health care through innovative research and strategic alliances. It allows us to expand our market beyond our traditional scope, which emphasizes and honors our mission of improving patient outcomes and shaping the future of health care policy.”
“Arbor’s growth over the years has been remarkable, and the GSA designation represents a significant step in expanding our reach beyond our traditional role, opening up new and exciting opportunities,” noted Chauncey R. Lynch, II, Chief Financial Officer, Arbor Research Collaborative for Health.
As pioneers in health care research, Arbor Research Collaborative for Health serves a diverse array of governmental, pharmaceutical, and private/foundation clients, illuminating new pathways in health care, driving progress and transformation across the industry. The unique structure of Arbor Research and Arbor Research LLC allows the organization to meet the needs of its expansive and diverse client base effectively.
Arbor Research Collaborative for Health has been awarded a new contract to develop and operate a secure, scalable, and innovative data registry system in support of Michigan’s Obstetrics Initiative (OBI). The initiative, one of several state-wide Collaborative Quality Initiatives (CQI), aims to improve maternal and neonatal outcomes across the state through advanced data-driven insights and
Request for Information: Arbor Research is soliciting information from qualified companies to participate in the PAn-european Registry Addressing Difelikefalin In Goal-oriented Medical treatment for dialysis-related pruritus (PARADIGM) study as the regulatory partner for Ethics Committee submission and coordination in the United Kingdom. Review details here: PARADIGM RFI UK
Arbor Research is pleased to announce the appointment of Fred Miller as its new Health IT Program Director. In this pivotal role, Mr. Miller will lead the strategic growth and delivery of our newly launched Health IT practice, positioning Arbor Research to meet the evolving digital health needs of federal agencies and industry partners alike.